Status:
COMPLETED
Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver Disease
Lead Sponsor:
Ningbo No. 1 Hospital
Conditions:
Nonalcoholic Fatty Liver Disease
Light-to-moderate Alcohol Consumption
Eligibility:
All Genders
18+ years
Brief Summary
This study explored the cross-sectional and prospective associations between light-to-moderate alcohol consumption (LMAC) and risk of type 2 diabetes mellitus (T2DM) in individuals with nonalcoholic f...
Eligibility Criteria
Inclusion
- aged 18 years or above
- undergoing annual health examinations in 2009 in Zhenhai Lianhua Hospital, Ningbo, China.
- informed about the study
Exclusion
- female participants;
- missing data on ultrasound, alcohol consumption, and T2DM status;
- alcohol consumption \> 210 g per week, and binge drinkers;
- with evidence of other liver diseases including viral hepatitis, autoimmune hepatitis, and drug-induced liver disease.
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 10 2019
Estimated Enrollment :
14014 Patients enrolled
Trial Details
Trial ID
NCT03847116
Start Date
January 1 2009
End Date
February 10 2019
Last Update
July 5 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ningbo first hospital
Ningbo, Zhejiang, China, 315010